We identified the expression of immune checkpoint protein CD155 on MB tumor cells and the expression of its inhibitory binding partner TIGIT on immune cells of MB patient-derived tissues, cell lines, and PDX MB organoids. This evidence concerns the gene PVR and neoplasm.